Journal Article10.1007/S10545-006-0351-7
Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixture
Guy Touati,Vassili Valayannopoulos,K. Mention,P. de Lonlay,Philippe Jouvet,Eliane Depondt,M. Assoun,J. C. Souberbielle,Daniel Rabier,H. Ogier de Baulny,J. M. Saudubray +10 more
112
TL;DR: 81 patients (51 MMA and 30 PA) diagnosed between 1988 and 2005 are reported in more detail, with severe forms followed for more than 3 years, and all patients but one have normal mental development.
read more
Abstract: In a series of 137 patients with methylmalonic acidaemia (MMA) and propionic acidaemia (PA) diagnosed since the early 1970s, we report in more detail 81 patients (51 MMA and 30 PA) diagnosed between 1988 and 2005. In this series, 14% of patients died at initial access revealing the disease before or despite treatment, 18% died later, and the remainder (68%) are still alive. All patients were treated with the same protocol of enteral feeds with a low-protein diet adjusted to individual tolerance, carnitine, antibiotics, and only occasional use of an amino acid (AA) mixture. There was intensive follow-up and monitoring using measurements of urinary urea. Thirty-nine patients with severe forms, followed for more than 3 years, are analysed in particular detail. Of the 17 PA patients, 6 had moderate disability (all neonatal-onset forms), whereas 11 were normal or slightly delayed in their mental development. Four presented with cardiomyopathy, of whom 2 died. Of the 22 MMA patients, 13 presented in the neonatal period, of whom 3 died later, 2 are in renal failure and only 5 are still alive and have a normal or slightly delayed mental development. In the 9 patients with late-onset forms, there were no deaths and all patients but one have normal mental development. Among the 39 patients, only 40% were given an AA supplement at 3 years, and 50% between 6 and 11 years. The actual intake of natural protein was 0.92, 0.78 and 0.77 g/kg per day at 3, 6 and 11 years, respectively, in patients without AA supplementation, whereas it was 0.75, 0.74 and 0.54 g/kg per day in the group who received small quantities of AA (0.4-0.6 g/kg per day). In both groups, feeding disorders were frequent: 55% at 3 years, 35% at 6 years and 12% at 11 years. Many patients were given a food supplement by tube overnight or were even exclusively tube fed: 60% at 3 years, 48% at 6 years and still 27% at 11 years. Growth velocity was near the normal values. Plasma valine and isoleucine were low to very low, as were leucine and phenylalanine but to a lesser extent. Albumin, vitamins, trace elements and markers of bone metabolism were within the normal values. IGF1, 24-hour urine calcium and body mass density were low. Body composition showed a normal to low lean mass and a normal to high fat mass.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors
TL;DR: The approach to adult patients with OA has to be multidisciplinary, with the clinician and dietician as the core of the team, but with the collaboration of clinical nurses specialists, social workers and other specialist services and the support of a biochemical and molecular laboratory.
Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea‐cycle disorders: On the basis of information from a European multicenter registry
Femke Molema,Florian Gleich,Peter Burgard,Ans T. van der Ploeg,Marshall L. Summar,Kimberly A. Chapman,Ivo Barić,Allan M. Lund,Stefan Kölker,Monique Williams +9 more
TL;DR: While MMA and PA patients who received AAMs‐OAD had very low BCAA levels and disturbed plasma BCAA ratios, A AMs‐UCD seemed to help UCD patients obtain normalBCAA levels.
Neurocognitive phenotype of isolated methylmalonic acidemia.
Colin J. O’Shea,Jennifer L. Sloan,Edythe Wiggs,Maryland Pao,Andrea L. Gropman,Andrea L. Gropman,Eva H. Baker,Irini Manoli,Charles P. Venditti,Joseph Snow +9 more
TL;DR: The neurocognitive outcomes seen in isolated MMA are highly variable, with an earlier age of disease onset, the presence of hyperammonemia at diagnosis, and a history of seizures associated with more severe impairment.
References
Hepatocyte transplantation for liver-based metabolic disorders.
TL;DR: Hepatocyte transplantation is being investigated as an alternative to orthotopic liver transplantation in patients with liver-based metabolic disorders, and considerable progress has been made in developing the technique, but hepatocyte transplation is limited by the available supply of liver tissue.
217
Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups.
TL;DR: Giving carnitine to a patient with methylmalonic aciduria produced an increase in hippurate excretion, an index of intramitochondrial adenosine triphosphate (ATP) and CoA availability, a large increase in short chain urinary acylcarnitines, and a reduction in excretion of methylmalonate and methylcitrate.
123
Clinical outcome and long-term management of 17 patients with propionic acidaemia.
S.B. van der Meer,F. Poggi,Marco Spada,Jean-Paul Bonnefont,H. Ogier,Philippe Hubert,E. Depondt,D. Rapoport,D. Rabier,C. Charpentier,P. Parvy,J. Bardet,P. Kamoun,J. M. Saudubray +13 more
TL;DR: The prognosis for patients with propionic acidaemia appeared to be satisfactory in terms of survival and outcome characteristics such as neurological and mental development, and the authors feel that the prognosis and quality of life of these patients might be improved with liver transplantation or possibly somatic gene therapy in the future.
82
Improved growth and nutrition status in children with methylmalonic or propionic acidemia fed an elemental medical food
Steven Yannicelli,Phyllis B. Acosta,Antonio Velázquez,Hans-Georg O. Bock,Barbara J. Marriage,Thaddeus W. Kurczynski,Marvin E. Miller,Mark S. Korson,Robert D. Steiner,Lane Rutledge,Laurie Bernstein,Jeffrey M. Chinsky,Patricia Galvin-Parton,Georgianne L. Arnold +13 more
TL;DR: Propimex-1 improved growth and nutrition status in patients with MMA or PA in just 6 months when fed in sufficient amounts when providing energy and protein at intakes recommended for catch-up growth may have resulted in even better growth.
57
The use of metronidazole in management of methylmalonic and propionic acidaemias
G. N. Thompson,Ronald A. Chalmers,John H. Walter,J. L. Bresson,Stanislas Lyonnet,P J Reed,J. M. Saudubray,James V. Leonard,D. Halliday +8 more
TL;DR: The results suggest that long-term antimicrobial therapy may offer significant clinical benefit to children with inborn errors of propionate metabolism.
54
Related Papers (5)
Matthias R. Baumgartner,Friederike Hörster,Carlo Dionisi-Vici,Goknur Haliloglu,Daniela Karall,Kimberly A. Chapman,Martina Huemer,Michel Hochuli,M. Assoun,Diana Ballhausen,Alberto Burlina,Brian Fowler,Sarah C. Grünert,Stephanie Grunewald,Tomas Honzik,Begoña Merinero,Celia Pérez-Cerdá,Sabine Scholl-Bürgi,Flemming Skovby,Frits A. Wijburg,Anita MacDonald,Diego Martinelli,Jörn Oliver Sass,Vassili Valayannopoulos,Anupam Chakrapani +24 more
R. A. Chalmers,A. M. Lawson +1 more
- 01 Jan 1982